Time to Stable Dose of Psychostimulants in Pediatric Patients With ADHD.
attention-deficit/hyperactivity disorder
behavior
pediatrics
psychostimulants
therapeutics
Journal
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
ISSN: 1551-6776
Titre abrégé: J Pediatr Pharmacol Ther
Pays: United States
ID NLM: 101089851
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
9
4
2020
Statut:
ppublish
Résumé
The prevalence of attention-deficit/hyperactivity disorder (ADHD) is increasing and psychostimulants are the pharmacological standard of care. Patients benefit most when there is efficient titration to a stable dose of medication as defined by maintaining that same dose for 6 months. The aims of this study were to describe time to stable dose in a cohort of children with ADHD and examine the impact of demographic factors. A list of pediatric patients with a diagnosis of ADHD in the electronic health record was generated, and a retrospective chart review of stimulant use was conducted on 500 patients randomly selected from 2010 to 2015 who met inclusion criteria. Time to stable dosing and its association with demographic characteristics were assessed. Patients were predominantly male (72%), white (81%), and privately insured (67%). Fifty-five percent of patients achieved a stable dose of medication on first attempt; therefore, the median time to stable dosing for the cohort was 0 days with the interquartile range being 0 to 133.8 days. There was significant increase in time to stable dose for patients younger than 10 years compared with those ≥10 years of age (p = 0.01). Time to stable dose was not significantly associated with race (p = 0.13), sex (p = 0.72), type of insurance (p = 0.56), or formulation being immediate or extended release (p = 0.56). Many patients had long titration periods when trying to reach a stable dose. Given that medication switching can be challenging for patients and families, more frequent contact with providers during titration may be necessary.
Identifiants
pubmed: 32265606
doi: 10.5863/1551-6776-25.3.228
pmc: PMC7134592
doi:
Types de publication
Journal Article
Langues
eng
Pagination
228-234Informations de copyright
Copyright Pediatric Pharmacy Association. All rights reserved. For permissions, email: mhelms@pediatricpharmacy.org 2020.
Déclaration de conflit d'intérêts
Disclosure The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts, and honoraria. The authors had full access to all the data and take responsibility for the integrity and accuracy of the data analysis.
Références
Cleve Clin J Med. 2017 Nov;84(11):873-880
pubmed: 29173249
J Am Acad Child Adolesc Psychiatry. 2010 Mar;49(3):217-28.e1-3
pubmed: 20410711
Arch Pediatr Adolesc Med. 2010 Feb;164(2):160-5
pubmed: 20124145
Dev Med Child Neurol. 1994 Dec;36(12):1099-107
pubmed: 7525394
J Clin Child Adolesc Psychol. 2018 Mar-Apr;47(2):199-212
pubmed: 29363986
J Am Acad Child Adolesc Psychiatry. 2015 Jul;54(7):550-6
pubmed: 26088659
J Pediatr Psychol. 2003 Dec;28(8):559-67
pubmed: 14602846
Pediatrics. 2015 Aug;136(2):351-9
pubmed: 26148950
Ann Fam Med. 2004 Sep-Oct;2(5):455-61
pubmed: 15506581
J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):987-9
pubmed: 23021475
J Atten Disord. 2015 Feb;19(2):99-117
pubmed: 23422237
Pediatrics. 2013 Jul;132(1):85-93
pubmed: 23796743
Am J Psychiatry. 2008 May;165(5):604-9
pubmed: 18381904
J Am Acad Child Adolesc Psychiatry. 1996 Aug;35(8):978-87
pubmed: 8755794
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):34-46.e2
pubmed: 24342384
Pediatrics. 2016 Sep;138(3):
pubmed: 27553219
Acad Pediatr. 2012 Mar-Apr;12(2):110-6
pubmed: 22326727
J Abnorm Child Psychol. 1981 Mar;9(1):43-54
pubmed: 7217537
J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):249-57
pubmed: 15725969
Psychiatry Investig. 2017 Mar;14(2):158-165
pubmed: 28326113
Psychiatry (Edgmont). 2006 Aug;3(8):36-45
pubmed: 20963194
Eur Child Adolesc Psychiatry. 2014 Jul;23(7):587-98
pubmed: 24166532